Ann: Investor Presentation, page-20

They expected approval by Chinas drug administration (forgot the name) to allow it to be sold as a medically approved substance. Was due in Dec 2019.

EHH have opened up 300 or so 'customer experience stores' across China and invested $1m into a high speed processing machine. They intend to sell into those stores.

Omni would receive royalties from sales.

Hoping something in the upcoming quarterly to confirm the above.

Honey is the money maker though - 21,000 units to be shipped in Jan 2020 to China.. at $14.50 a jar thats about $300,000 AUD.

(EDIT: Held. Hold.)